Insulin Argine is a human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. The primary activity of insulin, including Insulin Argine, is the regulation of glucose metabolism. Insulin and its analog lower blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulin Argine differs from human insulin in that two arginines are added to the C-terminus of the B-chain. Unfortunately Insulin Argine failed to demonstrate superior efficacy to regular human insulin and clinical development was discontinued
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1588835
30 mu/kg/h
Route of Administration:
Intravenous
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:53:56 GMT 2025
by
admin
on
Mon Mar 31 20:53:56 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
785P1QWQ1N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
16132322
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
785P1QWQ1N
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
6112
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
DTXSID50218951
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
C167008
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
DB11564
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108502
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
1740938
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
100000085459
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
68859-20-1
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
785P1QWQ1N
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY | |||
|
SUB08194MIG
Created by
admin on Mon Mar 31 20:53:56 GMT 2025 , Edited by admin on Mon Mar 31 20:53:56 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_7 | 2_7 |
| 1_19 | 2_20 |
| 2_6 | 2_11 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|